Multiple genetic mutations identified in thyroid cancer are receiving increasing attention, including BRAF, RAS, TERT, PIK3CA, AKT, PTEN, RET, TP53, and gene fusions of RET and NTRK [5, 6]. Here, AKT1 is linked to thyroid gland carcinoma.